These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 32977930)

  • 1. Reprint of: Examining Medicare Part D Medication Therapy Management program in the context of mental health.
    Murugappan MN; Seifert RD; Farley JF
    J Am Pharm Assoc (2003); 2020; 60(5S):S54-S63. PubMed ID: 32977930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining Medicare Part D Medication Therapy Management program in the context of mental health.
    Murugappan MN; Seifert RD; Farley JF
    J Am Pharm Assoc (2003); 2020; 60(4):571-579.e1. PubMed ID: 31953120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication Therapy Management Delivery by Community Pharmacists: Insights from a National Sample of Medicare Part D Beneficiaries.
    Adeoye OA; Farley JF; Coe AB; Pestka DL; Farris KB; Zillich AJ; Snyder ME
    J Am Coll Clin Pharm; 2019 Aug; 2(4):373-382. PubMed ID: 31460497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicare medication therapy Management: Beneficiary characteristics and utilization patterns in a national CMS Medicare fee-for-service sample (2013 to 2016).
    Oyarzún-González X; Abner EL; Freeman P; Kucharska-Newton A; Fardo DW; Moga DC
    J Am Pharm Assoc (2003); 2024; 64(5):102140. PubMed ID: 38825153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns and predictors of older adult Medicare Part D beneficiaries' receipt of medication therapy management.
    Coe AB; Adeoye-Olatunde OA; Pestka DL; Snyder ME; Zillich AJ; Farris KB; Farley JF
    Res Social Adm Pharm; 2020 Sep; 16(9):1208-1214. PubMed ID: 31859225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nationwide estimates of medication therapy management delivery under the Medicare prescription drug benefit.
    Pestka DL; Zillich AJ; Coe AB; Farris KB; Adeoye OA; Snyder ME; Farley JF
    J Am Pharm Assoc (2003); 2020; 60(3):456-461. PubMed ID: 31926872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive Medication Changes Resulting from Comprehensive and Noncomprehensive Medication Reviews in a Medicare Part D Population.
    Buhl A; Augustine J; Taylor AM; Martin R; Warholak TL
    J Manag Care Spec Pharm; 2017 Mar; 23(3):388-394. PubMed ID: 28230451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing Medicare beneficiaries' willingness-to-pay for medication therapy management services.
    Woelfel JA; Carr-Lopez SM; Delos Santos M; Bui A; Patel RA; Walberg MP; Galal SM
    Consult Pharm; 2014 Feb; 29(2):104-9. PubMed ID: 24513420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the impact of medication therapy management delivered to home-based Medicare beneficiaries.
    Welch EK; Delate T; Chester EA; Stubbings T
    Ann Pharmacother; 2009 Apr; 43(4):603-10. PubMed ID: 19318600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the Medicare Part D Comprehensive Medication Review on Racial and Ethnic Disparities in Medication Adherence.
    Dong X; Tsang CCS; Zhao S; Wan JY; Shih YT; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Hines LE; Wang J
    Am Health Drug Benefits; 2021 Sep; 14(3):101-109. PubMed ID: 35261713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of the Medicare Part D Medication Therapy Management Program from Inception in 2006 to the Present.
    Gray C; Cooke CE; Brandt N
    Am Health Drug Benefits; 2019 Sep; 12(5):243-251. PubMed ID: 32015791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey of medication therapy management programs under Medicare part D.
    Touchette DR; Burns AL; Bough MA; Blackburn JC
    J Am Pharm Assoc (2003); 2006; 46(6):683-91. PubMed ID: 17176683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial and ethnic disparities in Medicare Part D medication therapy management services utilization.
    Dong X; Tsang CCS; Browning JA; Garuccio J; Wan JY; Shih YCT; Chisholm-Burns MA; Dagogo-Jack S; Cushman WC; Wang J; Wang J
    Explor Res Clin Soc Pharm; 2023 Mar; 9():100222. PubMed ID: 36712831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Cost-Related Medication Non-adherence Among Older Adults With Medication Therapy Management.
    Zhang W; Lv G; Xiong X; Li M
    Front Med (Lausanne); 2021; 8():670034. PubMed ID: 34222282
    [No Abstract]   [Full Text] [Related]  

  • 15. Stimulating comprehensive medication reviews among Medicare Part D beneficiaries.
    Doucette WR; Pendergast JF; Zhang Y; Brown G; Chrischilles EA; Farris KB; Frank J
    Am J Manag Care; 2015 Jun; 21(6):e372-8. PubMed ID: 26247578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and implementation of a telephone medication therapy management program for Medicare beneficiaries.
    Moczygemba LR; Barner JC; Gabrillo ER; Godley PJ
    Am J Health Syst Pharm; 2008 Sep; 65(17):1655-60. PubMed ID: 18714113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between comprehensive medication review and medication adherence among medicare beneficiaries with chronic obstructive pulmonary disease.
    Zhang X; Sim Y; Tsang CCS; Wang J; Finch CK
    Explor Res Clin Soc Pharm; 2024 Sep; 15():100470. PubMed ID: 39050144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient satisfaction with a pharmacist-provided telephone medication therapy management program.
    Moczygemba LR; Barner JC; Brown CM; Lawson KA; Gabrillo ER; Godley P; Johnsrud M
    Res Social Adm Pharm; 2010 Jun; 6(2):143-54. PubMed ID: 20511113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of comprehensive medication reviews versus noncomprehensive medication review interventions and subsequent successful medication changes in a Medicare Part D population.
    Chinthammit C; Armstrong EP; Boesen K; Martin R; Taylor AM; Warholak T
    J Manag Care Spec Pharm; 2015 May; 21(5):381-9. PubMed ID: 25942999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the landscape of MTM programs for Medicare. Part D: Results from a study for the Centers for Medicare & Medicaid services.
    Shoemaker SJ; Hassol A
    J Am Pharm Assoc (2003); 2011; 51(4):520-6. PubMed ID: 21752775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.